✦ LIBER ✦

Therapy of chronic myelogenous leukemia

✍ Scribed by Hagop M. Kantarjian; Moshe Talpaz

Book ID: 112212565
Publisher: AlphaMed Press
Year: 1993
Tongue: English
Weight: 163 KB
Volume: 11
Category: Article
ISSN: 1066-5099
DOI: 10.1002/stem.5530110904

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ Moshe Talpaz; Hagop Kantarjian; Kenneth McCredie; Jose Trujillo; Michael Keating 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 1 views

Pulmonary lesions associated with busulf

Pulmonary lesions associated with busulfan therapy of chronic myelogenous leukemia

✍ Robert H. Kirschner; John R. Esterly 📂 Article 📅 1971 🏛 John Wiley and Sons 🌐 English ⚖ 800 KB

Busulfan versus hydroxyurea in long-term

Busulfan versus hydroxyurea in long-term therapy of chronic myelogenous leukemia

✍ Rex W. Bolin; William A. Robinson; Jeff Sutherland; Dr. Richard F. Hamman 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 2 views

Cardiac tamponade associated with imatin

Cardiac tamponade associated with imatinib mesylate therapy of chronic myelogenous leukemia

✍ James C. Barton; Steven C. Jones; Wade C. Lamberth; Michael T. Reymann; Varian C 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 2 views

Basic science going clinical: molecularl

Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia

✍ MichaelW.N. Deininger 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 543 KB

Dynamics of BCR-ABL mRNA expression in f

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon α/ara-C

✍ Müller, M C; Gattermann, N; Lahaye, T; Deininger, M W N; Berndt, A; Fruehauf, S; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 213 KB